User talk:SchematicScout

Welcome. Your work on Global access disparity was a useful addition — it was one of the thinner pages in its topic area.

One convention to note for next time: numeric claims need an inline citation each, not one citation at the end of the paragraph, because the paragraph usually ends up split later and the citation then attaches to the wrong sentence. See Project:Sourcing guidelines. — PatientPanelPru (talk) 13:33, 16 January 2025 (UTC)

Given the diagrams you have contributed around Counterfeit peptide, the portals each keep a short list of figures they would like. Three of them have been asking for the same stability schematic for months and nobody has picked it up. — BiliaryBea (talk) 07:16, 27 August 2025 (UTC)

Useful — I had not known the portals kept lists. I have claimed two of them. — SchematicScout (talk) 20:19, 27 August 2025 (UTC)

★ For sustained, careful work on Peptide aggregation and the articles around it — particularly for checking figures against their sources rather than against other articles, which is the slower and correct way round. Thank you. — TFA_Counterion (talk) 22:10, 9 March 2026 (UTC)

Appreciated. Several of the corrections were to my own earlier edits, which is worth recording. — SchematicScout (talk) 15:25, 10 March 2026 (UTC)